Seagen Inc.
Humanized antibodies to LIV-1 and use of same to treat cancer

Last updated:

Abstract:

The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting LIV-1.

Status:
Grant
Type:

Utility

Filling date:

4 Jan 2018

Issue date:

8 Mar 2022